| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiopulmonary Resuscitation | 94 | 2024 | 312 | 26.490 |
Why?
|
| Intubation, Intratracheal | 76 | 2023 | 291 | 24.470 |
Why?
|
| Laryngoscopes | 49 | 2023 | 68 | 20.300 |
Why?
|
| Manikins | 95 | 2023 | 134 | 16.070 |
Why?
|
| Allied Health Personnel | 39 | 2024 | 74 | 11.240 |
Why?
|
| Laryngoscopy | 32 | 2023 | 149 | 10.020 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 21 | 2024 | 87 | 7.930 |
Why?
|
| Emergency Medical Services | 33 | 2023 | 431 | 7.840 |
Why?
|
| Infusions, Intraosseous | 17 | 2021 | 20 | 7.550 |
Why?
|
| Cross-Over Studies | 80 | 2021 | 304 | 7.520 |
Why?
|
| Heart Arrest | 25 | 2024 | 341 | 7.420 |
Why?
|
| Personal Protective Equipment | 16 | 2022 | 54 | 7.080 |
Why?
|
| Heart Massage | 22 | 2023 | 30 | 6.860 |
Why?
|
| Pandemics | 42 | 2025 | 1104 | 6.580 |
Why?
|
| Resuscitation | 18 | 2022 | 244 | 5.120 |
Why?
|
| Emergency Medical Technicians | 13 | 2017 | 45 | 4.180 |
Why?
|
| Clinical Competence | 18 | 2020 | 977 | 4.090 |
Why?
|
| Humans | 324 | 2025 | 122633 | 4.060 |
Why?
|
| Acute Coronary Syndrome | 9 | 2024 | 198 | 4.050 |
Why?
|
| Pneumonia, Viral | 14 | 2021 | 376 | 3.920 |
Why?
|
| Airway Management | 16 | 2023 | 66 | 3.880 |
Why?
|
| Coronavirus Infections | 13 | 2020 | 360 | 3.560 |
Why?
|
| Poland | 35 | 2024 | 47 | 3.360 |
Why?
|
| Simulation Training | 17 | 2021 | 139 | 3.130 |
Why?
|
| Biomarkers | 17 | 2024 | 2935 | 2.820 |
Why?
|
| Nurses | 9 | 2021 | 62 | 2.810 |
Why?
|
| Betacoronavirus | 9 | 2020 | 288 | 2.800 |
Why?
|
| Vascular Stiffness | 5 | 2018 | 75 | 2.710 |
Why?
|
| Health Knowledge, Attitudes, Practice | 13 | 2024 | 821 | 2.660 |
Why?
|
| Adult | 105 | 2025 | 28881 | 2.540 |
Why?
|
| Emergency Medicine | 7 | 2020 | 154 | 2.450 |
Why?
|
| Equipment Design | 25 | 2023 | 598 | 2.390 |
Why?
|
| Kidney Transplantation | 7 | 2018 | 627 | 2.360 |
Why?
|
| Health Personnel | 11 | 2022 | 500 | 2.310 |
Why?
|
| Video Recording | 14 | 2020 | 181 | 2.290 |
Why?
|
| Takotsubo Cardiomyopathy | 6 | 2023 | 18 | 2.280 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 7 | 2022 | 41 | 2.130 |
Why?
|
| Disease Transmission, Infectious | 3 | 2020 | 85 | 1.980 |
Why?
|
| Male | 118 | 2025 | 59714 | 1.960 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 3 | 2023 | 22 | 1.960 |
Why?
|
| Female | 122 | 2025 | 65117 | 1.930 |
Why?
|
| Fluid Therapy | 5 | 2021 | 122 | 1.860 |
Why?
|
| Emergencies | 6 | 2020 | 175 | 1.820 |
Why?
|
| Laryngeal Masks | 8 | 2023 | 19 | 1.800 |
Why?
|
| Time Factors | 34 | 2023 | 6188 | 1.750 |
Why?
|
| Emergency Treatment | 4 | 2017 | 84 | 1.660 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2018 | 246 | 1.630 |
Why?
|
| Pyridazines | 3 | 2021 | 49 | 1.620 |
Why?
|
| Body Composition | 4 | 2018 | 478 | 1.600 |
Why?
|
| Kidney Failure, Chronic | 6 | 2022 | 866 | 1.590 |
Why?
|
| Firefighters | 3 | 2016 | 32 | 1.500 |
Why?
|
| Workplace | 2 | 2021 | 69 | 1.450 |
Why?
|
| Prospective Studies | 33 | 2025 | 6012 | 1.450 |
Why?
|
| Pneumonia, Ventilator-Associated | 2 | 2021 | 41 | 1.420 |
Why?
|
| Respiration, Artificial | 6 | 2021 | 455 | 1.410 |
Why?
|
| Hypothermia, Induced | 3 | 2022 | 158 | 1.400 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2021 | 223 | 1.310 |
Why?
|
| Education, Nursing | 2 | 2021 | 12 | 1.300 |
Why?
|
| Myocardial Infarction | 4 | 2021 | 997 | 1.290 |
Why?
|
| Defibrillators | 3 | 2018 | 21 | 1.290 |
Why?
|
| Infusions, Intravenous | 4 | 2021 | 533 | 1.280 |
Why?
|
| ST Elevation Myocardial Infarction | 2 | 2021 | 104 | 1.280 |
Why?
|
| Prognosis | 14 | 2024 | 4488 | 1.260 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2024 | 1033 | 1.250 |
Why?
|
| Restraint, Physical | 3 | 2020 | 28 | 1.220 |
Why?
|
| Middle Aged | 44 | 2025 | 25849 | 1.220 |
Why?
|
| Platelet Aggregation Inhibitors | 5 | 2021 | 256 | 1.210 |
Why?
|
| Heart Failure | 6 | 2023 | 2123 | 1.130 |
Why?
|
| Immobilization | 7 | 2020 | 23 | 1.130 |
Why?
|
| Young Adult | 31 | 2024 | 8817 | 1.120 |
Why?
|
| Wounds and Injuries | 3 | 2021 | 362 | 1.080 |
Why?
|
| Nutritional Status | 3 | 2017 | 296 | 1.040 |
Why?
|
| Child | 33 | 2023 | 24086 | 1.040 |
Why?
|
| Hospitals | 6 | 2023 | 397 | 1.030 |
Why?
|
| Cervical Vertebrae | 7 | 2020 | 104 | 1.000 |
Why?
|
| Lymphocytes | 2 | 2024 | 403 | 1.000 |
Why?
|
| Predictive Value of Tests | 7 | 2024 | 2100 | 0.980 |
Why?
|
| Vitamin D Deficiency | 2 | 2023 | 70 | 0.980 |
Why?
|
| Bilirubin | 2 | 2023 | 119 | 0.980 |
Why?
|
| Neutrophils | 2 | 2024 | 372 | 0.960 |
Why?
|
| Aged | 29 | 2025 | 18982 | 0.960 |
Why?
|
| Lipocalin-2 | 1 | 2024 | 28 | 0.920 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 2 | 2021 | 44 | 0.920 |
Why?
|
| Amiodarone | 2 | 2021 | 45 | 0.920 |
Why?
|
| Suction | 2 | 2021 | 57 | 0.910 |
Why?
|
| Postoperative Complications | 3 | 2023 | 2996 | 0.900 |
Why?
|
| Chest Pain | 2 | 2024 | 125 | 0.900 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2023 | 29 | 0.900 |
Why?
|
| Clinical Deterioration | 1 | 2023 | 11 | 0.890 |
Why?
|
| Hemodynamics | 4 | 2018 | 848 | 0.890 |
Why?
|
| Thoracic Injuries | 2 | 2016 | 90 | 0.890 |
Why?
|
| Extracorporeal Membrane Oxygenation | 6 | 2020 | 627 | 0.890 |
Why?
|
| Embolectomy | 1 | 2023 | 9 | 0.880 |
Why?
|
| Pulmonary Embolism | 2 | 2023 | 172 | 0.860 |
Why?
|
| Treatment Outcome | 24 | 2024 | 12055 | 0.860 |
Why?
|
| Catheterization, Peripheral | 2 | 2016 | 126 | 0.850 |
Why?
|
| Cholesterol, HDL | 1 | 2024 | 347 | 0.840 |
Why?
|
| Cardiovascular Diseases | 4 | 2020 | 1834 | 0.840 |
Why?
|
| Lacerations | 1 | 2023 | 34 | 0.830 |
Why?
|
| Occupational Diseases | 2 | 2014 | 74 | 0.830 |
Why?
|
| Living Donors | 1 | 2023 | 111 | 0.830 |
Why?
|
| Risk Assessment | 7 | 2024 | 3316 | 0.820 |
Why?
|
| Liver Transplantation | 2 | 2023 | 1007 | 0.810 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2023 | 60 | 0.810 |
Why?
|
| Monocytes | 1 | 2024 | 347 | 0.810 |
Why?
|
| Postural Orthostatic Tachycardia Syndrome | 1 | 2022 | 10 | 0.800 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 141 | 0.800 |
Why?
|
| Ischemic Attack, Transient | 1 | 2022 | 51 | 0.800 |
Why?
|
| Occupational Exposure | 4 | 2020 | 129 | 0.800 |
Why?
|
| White Matter | 1 | 2024 | 181 | 0.790 |
Why?
|
| Milrinone | 1 | 2022 | 30 | 0.790 |
Why?
|
| Catheters | 2 | 2020 | 89 | 0.790 |
Why?
|
| Education, Medical, Continuing | 3 | 2021 | 140 | 0.790 |
Why?
|
| Shock | 2 | 2020 | 89 | 0.790 |
Why?
|
| Atrial Flutter | 1 | 2021 | 32 | 0.770 |
Why?
|
| Thrombolytic Therapy | 1 | 2023 | 203 | 0.770 |
Why?
|
| Masks | 3 | 2020 | 39 | 0.770 |
Why?
|
| Heart Injuries | 1 | 2021 | 46 | 0.760 |
Why?
|
| Ultrasonography | 5 | 2021 | 944 | 0.750 |
Why?
|
| Needles | 2 | 2020 | 51 | 0.740 |
Why?
|
| Renal Dialysis | 3 | 2022 | 842 | 0.740 |
Why?
|
| Mucormycosis | 1 | 2021 | 26 | 0.740 |
Why?
|
| Pneumonia, Aspiration | 1 | 2021 | 17 | 0.740 |
Why?
|
| Tranexamic Acid | 1 | 2021 | 19 | 0.730 |
Why?
|
| Dextrans | 1 | 2020 | 45 | 0.730 |
Why?
|
| Infection Control | 6 | 2022 | 160 | 0.730 |
Why?
|
| Public Health | 4 | 2024 | 254 | 0.720 |
Why?
|
| Shock, Cardiogenic | 1 | 2022 | 189 | 0.720 |
Why?
|
| Braces | 2 | 2018 | 14 | 0.720 |
Why?
|
| Endovascular Procedures | 3 | 2025 | 717 | 0.720 |
Why?
|
| Myocarditis | 1 | 2021 | 119 | 0.720 |
Why?
|
| Physicians | 7 | 2018 | 583 | 0.710 |
Why?
|
| Ferritins | 1 | 2020 | 96 | 0.710 |
Why?
|
| Vascular Access Devices | 2 | 2020 | 35 | 0.710 |
Why?
|
| Ventricular Fibrillation | 2 | 2021 | 51 | 0.710 |
Why?
|
| Disposable Equipment | 1 | 2020 | 15 | 0.700 |
Why?
|
| Equipment Reuse | 1 | 2020 | 8 | 0.700 |
Why?
|
| Textiles | 1 | 2020 | 10 | 0.700 |
Why?
|
| Anesthesiologists | 1 | 2020 | 35 | 0.690 |
Why?
|
| Shock, Hemorrhagic | 1 | 2020 | 50 | 0.690 |
Why?
|
| Pediatric Emergency Medicine | 1 | 2020 | 49 | 0.690 |
Why?
|
| Aged, 80 and over | 14 | 2023 | 6341 | 0.690 |
Why?
|
| Random Allocation | 6 | 2019 | 412 | 0.690 |
Why?
|
| Stroke | 3 | 2022 | 957 | 0.680 |
Why?
|
| Dental Hygienists | 1 | 2019 | 5 | 0.670 |
Why?
|
| Education, Medical, Graduate | 3 | 2020 | 510 | 0.660 |
Why?
|
| Ketamine | 1 | 2023 | 209 | 0.660 |
Why?
|
| Dental Offices | 1 | 2019 | 3 | 0.660 |
Why?
|
| Formative Feedback | 2 | 2018 | 28 | 0.660 |
Why?
|
| Cardiologists | 1 | 2019 | 20 | 0.660 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 73 | 0.650 |
Why?
|
| Emergency Service, Hospital | 8 | 2023 | 1067 | 0.650 |
Why?
|
| Fiber Optic Technology | 2 | 2016 | 46 | 0.640 |
Why?
|
| Acute Kidney Injury | 2 | 2023 | 607 | 0.630 |
Why?
|
| Cardiology | 2 | 2021 | 472 | 0.630 |
Why?
|
| Premature Birth | 1 | 2023 | 379 | 0.630 |
Why?
|
| Shock, Septic | 1 | 2020 | 148 | 0.630 |
Why?
|
| Hypotension | 1 | 2020 | 175 | 0.630 |
Why?
|
| Lung | 4 | 2021 | 1468 | 0.620 |
Why?
|
| Feedback | 3 | 2019 | 160 | 0.620 |
Why?
|
| Surveys and Questionnaires | 14 | 2025 | 3648 | 0.620 |
Why?
|
| Blood Pressure | 4 | 2018 | 1309 | 0.610 |
Why?
|
| Transplant Recipients | 2 | 2017 | 209 | 0.610 |
Why?
|
| Anaphylaxis | 2 | 2016 | 77 | 0.600 |
Why?
|
| Pulse Wave Analysis | 4 | 2018 | 47 | 0.600 |
Why?
|
| Glycopeptides | 3 | 2022 | 26 | 0.590 |
Why?
|
| Practice Patterns, Nurses' | 1 | 2017 | 8 | 0.590 |
Why?
|
| Pressure | 7 | 2018 | 130 | 0.590 |
Why?
|
| Mass Casualty Incidents | 2 | 2015 | 17 | 0.590 |
Why?
|
| Basal Metabolism | 1 | 2018 | 89 | 0.590 |
Why?
|
| Risk Factors | 13 | 2023 | 9943 | 0.590 |
Why?
|
| Elective Surgical Procedures | 2 | 2017 | 160 | 0.570 |
Why?
|
| Registries | 5 | 2023 | 1379 | 0.570 |
Why?
|
| Poisoning | 1 | 2017 | 16 | 0.570 |
Why?
|
| Ultrasonography, Interventional | 2 | 2016 | 196 | 0.570 |
Why?
|
| Hemodynamic Monitoring | 1 | 2017 | 12 | 0.570 |
Why?
|
| Atrial Fibrillation | 2 | 2021 | 623 | 0.570 |
Why?
|
| Dobutamine | 3 | 2022 | 56 | 0.570 |
Why?
|
| Cadaver | 5 | 2019 | 131 | 0.560 |
Why?
|
| Air Ambulances | 1 | 2017 | 25 | 0.560 |
Why?
|
| Medical Staff, Hospital | 2 | 2017 | 92 | 0.560 |
Why?
|
| Video-Assisted Surgery | 1 | 2016 | 5 | 0.560 |
Why?
|
| Internship and Residency | 2 | 2018 | 1158 | 0.550 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2017 | 77 | 0.550 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2016 | 6 | 0.540 |
Why?
|
| Central Venous Catheters | 1 | 2017 | 38 | 0.540 |
Why?
|
| Adipose Tissue | 2 | 2018 | 447 | 0.540 |
Why?
|
| Occupational Health | 3 | 2021 | 44 | 0.540 |
Why?
|
| Heart Diseases | 1 | 2021 | 481 | 0.530 |
Why?
|
| Emergency Nursing | 4 | 2016 | 9 | 0.530 |
Why?
|
| Mental Disorders | 1 | 2023 | 824 | 0.530 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 686 | 0.520 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2016 | 57 | 0.520 |
Why?
|
| Symptom Assessment | 1 | 2016 | 98 | 0.520 |
Why?
|
| Practice Guidelines as Topic | 6 | 2018 | 1248 | 0.510 |
Why?
|
| Electrocardiography | 3 | 2022 | 961 | 0.510 |
Why?
|
| Lactic Acid | 1 | 2016 | 140 | 0.510 |
Why?
|
| Kidney | 3 | 2017 | 1337 | 0.510 |
Why?
|
| Pneumothorax | 1 | 2016 | 81 | 0.490 |
Why?
|
| Gloves, Surgical | 1 | 2015 | 4 | 0.490 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 713 | 0.490 |
Why?
|
| Retrospective Studies | 14 | 2023 | 15916 | 0.480 |
Why?
|
| Disaster Planning | 2 | 2015 | 65 | 0.480 |
Why?
|
| Intracranial Pressure | 1 | 2016 | 175 | 0.480 |
Why?
|
| Optic Nerve | 1 | 2016 | 117 | 0.480 |
Why?
|
| Chemical Hazard Release | 1 | 2014 | 1 | 0.470 |
Why?
|
| Catheterization, Central Venous | 1 | 2016 | 130 | 0.470 |
Why?
|
| Intracranial Hypertension | 1 | 2016 | 116 | 0.470 |
Why?
|
| Decontamination | 1 | 2014 | 12 | 0.470 |
Why?
|
| Craniocerebral Trauma | 2 | 2015 | 125 | 0.470 |
Why?
|
| Trachea | 1 | 2016 | 201 | 0.460 |
Why?
|
| Esophagus | 1 | 2016 | 212 | 0.460 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2015 | 204 | 0.460 |
Why?
|
| Thyroidectomy | 1 | 2015 | 100 | 0.460 |
Why?
|
| Thyroid Gland | 1 | 2015 | 112 | 0.460 |
Why?
|
| Gloves, Protective | 1 | 2014 | 4 | 0.460 |
Why?
|
| Anesthesiology | 1 | 2015 | 97 | 0.450 |
Why?
|
| Computer Simulation | 1 | 2017 | 616 | 0.450 |
Why?
|
| Equipment Contamination | 1 | 2014 | 38 | 0.440 |
Why?
|
| Europe | 3 | 2021 | 369 | 0.440 |
Why?
|
| Infant | 14 | 2022 | 12272 | 0.440 |
Why?
|
| Telemedicine | 1 | 2019 | 421 | 0.440 |
Why?
|
| Infant, Newborn | 10 | 2023 | 8064 | 0.430 |
Why?
|
| Asepsis | 1 | 2013 | 1 | 0.430 |
Why?
|
| Universal Precautions | 1 | 2013 | 4 | 0.430 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 481 | 0.430 |
Why?
|
| Antisepsis | 1 | 2013 | 10 | 0.420 |
Why?
|
| Knowledge | 1 | 2013 | 45 | 0.420 |
Why?
|
| Italy | 3 | 2021 | 111 | 0.420 |
Why?
|
| Hydrazones | 3 | 2021 | 19 | 0.420 |
Why?
|
| Inpatients | 1 | 2017 | 490 | 0.420 |
Why?
|
| Vitamin D | 3 | 2023 | 158 | 0.410 |
Why?
|
| Accidents | 1 | 2012 | 15 | 0.400 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 1101 | 0.400 |
Why?
|
| Single-Blind Method | 3 | 2021 | 234 | 0.390 |
Why?
|
| Cross-Sectional Studies | 9 | 2025 | 3341 | 0.390 |
Why?
|
| Ribs | 1 | 2012 | 44 | 0.390 |
Why?
|
| Vascular Diseases | 2 | 2023 | 162 | 0.390 |
Why?
|
| Hyperkalemia | 2 | 2023 | 65 | 0.390 |
Why?
|
| Pregnant Women | 2 | 2023 | 148 | 0.380 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 933 | 0.380 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2022 | 62 | 0.380 |
Why?
|
| Dietary Supplements | 4 | 2022 | 462 | 0.380 |
Why?
|
| Lidocaine | 2 | 2021 | 48 | 0.360 |
Why?
|
| Pregnancy | 8 | 2025 | 7105 | 0.360 |
Why?
|
| Surgeons | 1 | 2015 | 247 | 0.360 |
Why?
|
| Patient Discharge | 4 | 2023 | 488 | 0.360 |
Why?
|
| Incidence | 6 | 2022 | 3040 | 0.350 |
Why?
|
| Quality of Life | 3 | 2022 | 1921 | 0.350 |
Why?
|
| Accidents, Traffic | 3 | 2016 | 101 | 0.350 |
Why?
|
| Cardiotonic Agents | 2 | 2022 | 137 | 0.350 |
Why?
|
| First Aid | 2 | 2021 | 5 | 0.340 |
Why?
|
| Patient Positioning | 3 | 2020 | 54 | 0.340 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2023 | 274 | 0.340 |
Why?
|
| Glasgow Coma Scale | 3 | 2021 | 199 | 0.330 |
Why?
|
| Depressive Disorder, Major | 2 | 2024 | 398 | 0.330 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2395 | 0.330 |
Why?
|
| Thrombosis | 2 | 2025 | 517 | 0.320 |
Why?
|
| Students | 2 | 2024 | 248 | 0.320 |
Why?
|
| Thorax | 3 | 2023 | 72 | 0.300 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2022 | 457 | 0.300 |
Why?
|
| Thumb | 5 | 2018 | 29 | 0.300 |
Why?
|
| Vitamins | 3 | 2023 | 106 | 0.300 |
Why?
|
| Body Mass Index | 3 | 2018 | 1469 | 0.300 |
Why?
|
| Electric Countershock | 2 | 2018 | 67 | 0.300 |
Why?
|
| Respiratory Tract Infections | 2 | 2020 | 263 | 0.290 |
Why?
|
| Child, Preschool | 6 | 2021 | 13794 | 0.290 |
Why?
|
| Attitude | 2 | 2019 | 119 | 0.280 |
Why?
|
| Education, Medical | 2 | 2024 | 285 | 0.280 |
Why?
|
| Postoperative Period | 2 | 2018 | 330 | 0.280 |
Why?
|
| Guidelines as Topic | 2 | 2020 | 194 | 0.280 |
Why?
|
| Critical Care | 3 | 2018 | 650 | 0.280 |
Why?
|
| Recovery of Function | 2 | 2020 | 435 | 0.280 |
Why?
|
| Hospitalization | 4 | 2023 | 1730 | 0.270 |
Why?
|
| Resistance Training | 2 | 2017 | 32 | 0.270 |
Why?
|
| Stress, Psychological | 3 | 2021 | 555 | 0.270 |
Why?
|
| Adolescent | 11 | 2024 | 18987 | 0.260 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2024 | 218 | 0.260 |
Why?
|
| Double-Blind Method | 2 | 2023 | 1576 | 0.260 |
Why?
|
| Gynecology | 2 | 2025 | 127 | 0.250 |
Why?
|
| American Heart Association | 2 | 2018 | 293 | 0.250 |
Why?
|
| Education, Nursing, Continuing | 2 | 2015 | 19 | 0.250 |
Why?
|
| Psilocybin | 1 | 2024 | 4 | 0.250 |
Why?
|
| Love | 1 | 2024 | 4 | 0.240 |
Why?
|
| Optimism | 1 | 2024 | 4 | 0.240 |
Why?
|
| Protective Factors | 2 | 2022 | 83 | 0.240 |
Why?
|
| Sexuality | 1 | 2024 | 15 | 0.240 |
Why?
|
| Cause of Death | 2 | 2020 | 455 | 0.240 |
Why?
|
| Hope | 1 | 2024 | 13 | 0.240 |
Why?
|
| Nasal Sprays | 1 | 2024 | 8 | 0.240 |
Why?
|
| Dextromethorphan | 1 | 2024 | 11 | 0.240 |
Why?
|
| Obstetrics | 2 | 2025 | 233 | 0.230 |
Why?
|
| Bupropion | 1 | 2024 | 26 | 0.230 |
Why?
|
| Expert Testimony | 3 | 2021 | 36 | 0.230 |
Why?
|
| Students, Medical | 2 | 2021 | 358 | 0.230 |
Why?
|
| Respiratory Protective Devices | 2 | 2020 | 9 | 0.230 |
Why?
|
| Hallucinogens | 1 | 2024 | 41 | 0.230 |
Why?
|
| Zinc | 2 | 2022 | 128 | 0.230 |
Why?
|
| Equipment Failure | 2 | 2015 | 123 | 0.230 |
Why?
|
| Anticoagulants | 3 | 2023 | 585 | 0.230 |
Why?
|
| Chitosan | 1 | 2023 | 21 | 0.220 |
Why?
|
| Affect | 1 | 2024 | 154 | 0.220 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 5019 | 0.220 |
Why?
|
| Hospital Mortality | 3 | 2023 | 1001 | 0.220 |
Why?
|
| Leukocyte Count | 1 | 2024 | 247 | 0.220 |
Why?
|
| Self Concept | 1 | 2024 | 156 | 0.220 |
Why?
|
| Tongue Diseases | 1 | 2023 | 11 | 0.220 |
Why?
|
| Deafness | 1 | 2023 | 81 | 0.210 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2024 | 107 | 0.210 |
Why?
|
| Protein Precursors | 1 | 2023 | 149 | 0.210 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 1864 | 0.210 |
Why?
|
| Transgender Persons | 1 | 2024 | 59 | 0.210 |
Why?
|
| Fentanyl | 1 | 2023 | 43 | 0.210 |
Why?
|
| Epinephrine | 2 | 2021 | 174 | 0.210 |
Why?
|
| Administration, Intranasal | 1 | 2023 | 130 | 0.210 |
Why?
|
| Multicenter Studies as Topic | 2 | 2020 | 263 | 0.210 |
Why?
|
| Virulence | 2 | 2020 | 258 | 0.210 |
Why?
|
| Adrenomedullin | 1 | 2023 | 74 | 0.210 |
Why?
|
| Trace Elements | 1 | 2022 | 24 | 0.210 |
Why?
|
| Pediatrics | 3 | 2021 | 1137 | 0.210 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2022 | 17 | 0.200 |
Why?
|
| Pilot Projects | 4 | 2025 | 1380 | 0.200 |
Why?
|
| Ascorbic Acid | 1 | 2022 | 77 | 0.200 |
Why?
|
| Social Support | 1 | 2024 | 343 | 0.200 |
Why?
|
| Attitude of Health Personnel | 4 | 2024 | 639 | 0.200 |
Why?
|
| Troponin I | 1 | 2023 | 98 | 0.200 |
Why?
|
| Burnout, Professional | 1 | 2024 | 115 | 0.200 |
Why?
|
| Cystatin C | 1 | 2022 | 49 | 0.200 |
Why?
|
| Models, Cardiovascular | 2 | 2020 | 178 | 0.200 |
Why?
|
| Blood Platelets | 1 | 2025 | 333 | 0.200 |
Why?
|
| Coronary Artery Disease | 2 | 2019 | 743 | 0.200 |
Why?
|
| Analgesics | 1 | 2023 | 131 | 0.200 |
Why?
|
| Heel | 1 | 2021 | 9 | 0.200 |
Why?
|
| Vitamin K | 1 | 2022 | 35 | 0.200 |
Why?
|
| Time-to-Treatment | 2 | 2021 | 186 | 0.190 |
Why?
|
| Fibrinolytic Agents | 1 | 2023 | 199 | 0.190 |
Why?
|
| Blood Coagulation Disorders | 1 | 2023 | 100 | 0.190 |
Why?
|
| Abdomen | 1 | 2022 | 129 | 0.190 |
Why?
|
| Coronary Angiography | 3 | 2023 | 417 | 0.190 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2022 | 112 | 0.190 |
Why?
|
| High Fidelity Simulation Training | 1 | 2021 | 4 | 0.190 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2021 | 21 | 0.190 |
Why?
|
| Health Behavior | 1 | 2024 | 378 | 0.190 |
Why?
|
| Clinical Decision-Making | 2 | 2020 | 266 | 0.190 |
Why?
|
| Printing, Three-Dimensional | 1 | 2022 | 69 | 0.190 |
Why?
|
| Counterfeit Drugs | 1 | 2020 | 1 | 0.190 |
Why?
|
| Models, Anatomic | 1 | 2022 | 98 | 0.190 |
Why?
|
| Interleukin-6 | 1 | 2023 | 393 | 0.190 |
Why?
|
| Pancreas | 1 | 2022 | 209 | 0.190 |
Why?
|
| Sex Distribution | 2 | 2012 | 286 | 0.190 |
Why?
|
| Anesthesia, General | 2 | 2023 | 111 | 0.180 |
Why?
|
| Angioplasty, Balloon | 1 | 2022 | 161 | 0.180 |
Why?
|
| Age Distribution | 2 | 2012 | 404 | 0.180 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2020 | 20 | 0.180 |
Why?
|
| Antifibrinolytic Agents | 1 | 2021 | 33 | 0.180 |
Why?
|
| Cardiac Output, Low | 1 | 2021 | 66 | 0.180 |
Why?
|
| Education, Distance | 1 | 2021 | 66 | 0.180 |
Why?
|
| Immunoassay | 1 | 2021 | 127 | 0.180 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 43 | 0.180 |
Why?
|
| Leg | 1 | 2021 | 154 | 0.180 |
Why?
|
| Punctures | 1 | 2020 | 55 | 0.180 |
Why?
|
| Israel | 3 | 2025 | 44 | 0.180 |
Why?
|
| Drug Packaging | 1 | 2020 | 7 | 0.180 |
Why?
|
| Stroke Volume | 1 | 2022 | 448 | 0.180 |
Why?
|
| Prone Position | 1 | 2020 | 32 | 0.180 |
Why?
|
| Infectious Disease Incubation Period | 1 | 2020 | 7 | 0.180 |
Why?
|
| Inhalation Exposure | 1 | 2020 | 36 | 0.180 |
Why?
|
| Pets | 1 | 2020 | 15 | 0.180 |
Why?
|
| Seasons | 2 | 2012 | 300 | 0.180 |
Why?
|
| Hypoglycemia | 1 | 2022 | 191 | 0.180 |
Why?
|
| Hemorrhage | 2 | 2022 | 458 | 0.180 |
Why?
|
| Surge Capacity | 1 | 2020 | 9 | 0.180 |
Why?
|
| Syringes | 1 | 2020 | 24 | 0.180 |
Why?
|
| Alanine | 1 | 2020 | 181 | 0.170 |
Why?
|
| Severity of Illness Index | 4 | 2023 | 2837 | 0.170 |
Why?
|
| Immune System | 1 | 2020 | 86 | 0.170 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 162 | 0.170 |
Why?
|
| Adenoviridae Infections | 1 | 2020 | 68 | 0.170 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 86 | 0.170 |
Why?
|
| Cardiac Tamponade | 1 | 2020 | 37 | 0.170 |
Why?
|
| Reference Standards | 1 | 2020 | 240 | 0.170 |
Why?
|
| Cardiac Care Facilities | 1 | 2019 | 8 | 0.170 |
Why?
|
| Critical Pathways | 1 | 2020 | 68 | 0.170 |
Why?
|
| Survival Analysis | 2 | 2021 | 1466 | 0.170 |
Why?
|
| China | 1 | 2020 | 236 | 0.170 |
Why?
|
| Mammary Arteries | 1 | 2019 | 26 | 0.170 |
Why?
|
| Patient Selection | 2 | 2020 | 684 | 0.170 |
Why?
|
| Respiratory System | 1 | 2020 | 95 | 0.170 |
Why?
|
| Internet | 1 | 2022 | 376 | 0.160 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2020 | 92 | 0.160 |
Why?
|
| Respiratory Aspiration of Gastric Contents | 1 | 2019 | 1 | 0.160 |
Why?
|
| Dentists | 1 | 2019 | 7 | 0.160 |
Why?
|
| Laryngopharyngeal Reflux | 1 | 2019 | 4 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2018 | 4686 | 0.160 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2019 | 94 | 0.160 |
Why?
|
| Curriculum | 1 | 2024 | 718 | 0.160 |
Why?
|
| Patient Care Team | 1 | 2023 | 546 | 0.160 |
Why?
|
| Brain Ischemia | 1 | 2021 | 251 | 0.160 |
Why?
|
| Gestational Age | 1 | 2023 | 1115 | 0.160 |
Why?
|
| Cesarean Section | 1 | 2022 | 380 | 0.160 |
Why?
|
| Swimming Pools | 1 | 2018 | 7 | 0.160 |
Why?
|
| Preliminary Data | 1 | 2018 | 7 | 0.160 |
Why?
|
| High-Frequency Jet Ventilation | 1 | 2018 | 3 | 0.160 |
Why?
|
| Cytokines | 2 | 2023 | 1280 | 0.160 |
Why?
|
| Positive-Pressure Respiration | 1 | 2019 | 83 | 0.160 |
Why?
|
| Emergency Responders | 1 | 2018 | 18 | 0.160 |
Why?
|
| Teacher Training | 1 | 2018 | 6 | 0.160 |
Why?
|
| Optic Nerve Diseases | 1 | 2020 | 88 | 0.160 |
Why?
|
| Toxoplasmosis | 1 | 2018 | 19 | 0.160 |
Why?
|
| School Teachers | 1 | 2018 | 8 | 0.160 |
Why?
|
| Antifungal Agents | 1 | 2021 | 293 | 0.160 |
Why?
|
| Stress, Physiological | 1 | 2020 | 263 | 0.160 |
Why?
|
| Pulmonary Ventilation | 1 | 2018 | 28 | 0.160 |
Why?
|
| Oscillometry | 1 | 2018 | 15 | 0.160 |
Why?
|
| Global Health | 2 | 2020 | 557 | 0.150 |
Why?
|
| Glottis | 1 | 2018 | 31 | 0.150 |
Why?
|
| Patient Comfort | 1 | 2018 | 4 | 0.150 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 354 | 0.150 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2018 | 25 | 0.150 |
Why?
|
| Tracheostomy | 1 | 2021 | 191 | 0.150 |
Why?
|
| Brachial Artery | 1 | 2018 | 38 | 0.150 |
Why?
|
| Patient Admission | 1 | 2019 | 184 | 0.150 |
Why?
|
| Syndrome | 1 | 2021 | 1111 | 0.150 |
Why?
|
| Public Facilities | 1 | 2017 | 2 | 0.150 |
Why?
|
| Long QT Syndrome | 1 | 2018 | 86 | 0.150 |
Why?
|
| Linear Models | 2 | 2018 | 664 | 0.150 |
Why?
|
| Educational Measurement | 1 | 2020 | 323 | 0.150 |
Why?
|
| Blood Pressure Determination | 1 | 2018 | 105 | 0.150 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2018 | 38 | 0.150 |
Why?
|
| Equipment and Supplies | 1 | 2017 | 23 | 0.150 |
Why?
|
| Coronary Circulation | 1 | 2018 | 209 | 0.140 |
Why?
|
| Cross Infection | 1 | 2021 | 332 | 0.140 |
Why?
|
| Incisor | 1 | 2017 | 7 | 0.140 |
Why?
|
| Tooth Injuries | 1 | 2017 | 4 | 0.140 |
Why?
|
| Body Fluids | 1 | 2017 | 48 | 0.140 |
Why?
|
| Intensive Care Units | 1 | 2021 | 482 | 0.140 |
Why?
|
| Viral Vaccines | 1 | 2020 | 325 | 0.140 |
Why?
|
| Communicable Disease Control | 2 | 2020 | 141 | 0.140 |
Why?
|
| Cardiovascular System | 1 | 2018 | 99 | 0.140 |
Why?
|
| Cardiac Output | 1 | 2017 | 168 | 0.140 |
Why?
|
| Disease Progression | 1 | 2023 | 2024 | 0.140 |
Why?
|
| Optical Fibers | 1 | 2016 | 17 | 0.140 |
Why?
|
| Health Education | 1 | 2018 | 222 | 0.140 |
Why?
|
| Arterial Pressure | 1 | 2017 | 104 | 0.140 |
Why?
|
| Desensitization, Immunologic | 1 | 2018 | 95 | 0.140 |
Why?
|
| Platelet Aggregation | 1 | 2017 | 120 | 0.140 |
Why?
|
| Thyroid Cartilage | 1 | 2016 | 5 | 0.130 |
Why?
|
| Humeral Head | 1 | 2016 | 5 | 0.130 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2018 | 107 | 0.130 |
Why?
|
| Cricoid Cartilage | 1 | 2016 | 16 | 0.130 |
Why?
|
| Education, Continuing | 1 | 2016 | 29 | 0.130 |
Why?
|
| Respiration Disorders | 1 | 2016 | 30 | 0.130 |
Why?
|
| Critical Illness | 1 | 2020 | 594 | 0.130 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2018 | 141 | 0.130 |
Why?
|
| Tibia | 1 | 2016 | 70 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 134 | 0.130 |
Why?
|
| Adjuvants, Immunologic | 1 | 2018 | 376 | 0.130 |
Why?
|
| Parturition | 1 | 2016 | 62 | 0.130 |
Why?
|
| Allergens | 1 | 2018 | 244 | 0.130 |
Why?
|
| Prenatal Care | 1 | 2018 | 340 | 0.130 |
Why?
|
| Personnel, Hospital | 1 | 2015 | 35 | 0.130 |
Why?
|
| Bronchoscopes | 1 | 2015 | 5 | 0.130 |
Why?
|
| Text Messaging | 1 | 2015 | 30 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 2017 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 439 | 0.120 |
Why?
|
| Overweight | 1 | 2018 | 344 | 0.120 |
Why?
|
| Mass Screening | 1 | 2021 | 786 | 0.120 |
Why?
|
| Professional Competence | 1 | 2016 | 97 | 0.120 |
Why?
|
| Fatigue | 1 | 2016 | 217 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2020 | 731 | 0.120 |
Why?
|
| Organ Size | 1 | 2016 | 411 | 0.120 |
Why?
|
| Turkey | 2 | 2024 | 57 | 0.120 |
Why?
|
| Catheters, Indwelling | 1 | 2016 | 156 | 0.120 |
Why?
|
| Multiple Trauma | 1 | 2015 | 63 | 0.120 |
Why?
|
| Chemical Terrorism | 1 | 2014 | 1 | 0.120 |
Why?
|
| Abdominal Injuries | 1 | 2015 | 108 | 0.120 |
Why?
|
| Aortic Valve | 1 | 2018 | 425 | 0.120 |
Why?
|
| Inflammation | 1 | 2021 | 1398 | 0.120 |
Why?
|
| Teaching | 1 | 2016 | 182 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2016 | 757 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2018 | 3256 | 0.120 |
Why?
|
| Physician's Role | 1 | 2016 | 164 | 0.120 |
Why?
|
| Body Weight | 1 | 2018 | 959 | 0.110 |
Why?
|
| Evaluation Studies as Topic | 1 | 2014 | 258 | 0.110 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2015 | 92 | 0.110 |
Why?
|
| Societies, Medical | 1 | 2018 | 676 | 0.110 |
Why?
|
| Aortic Valve Stenosis | 1 | 2018 | 322 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2016 | 375 | 0.110 |
Why?
|
| Cardiac Catheterization | 1 | 2018 | 632 | 0.110 |
Why?
|
| Delivery, Obstetric | 1 | 2016 | 253 | 0.110 |
Why?
|
| Age Factors | 4 | 2024 | 2788 | 0.110 |
Why?
|
| Health Care Surveys | 1 | 2014 | 284 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3506 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 845 | 0.100 |
Why?
|
| Prevalence | 1 | 2019 | 2388 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2821 | 0.100 |
Why?
|
| United States | 2 | 2018 | 10559 | 0.100 |
Why?
|
| Edema | 2 | 2023 | 134 | 0.100 |
Why?
|
| Causality | 1 | 2012 | 78 | 0.100 |
Why?
|
| Educational Status | 1 | 2013 | 268 | 0.100 |
Why?
|
| Contrast Media | 1 | 2015 | 469 | 0.100 |
Why?
|
| Anxiety | 1 | 2018 | 953 | 0.100 |
Why?
|
| Stents | 1 | 2018 | 866 | 0.090 |
Why?
|
| Communication | 1 | 2015 | 510 | 0.090 |
Why?
|
| Injury Severity Score | 1 | 2011 | 219 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2013 | 383 | 0.090 |
Why?
|
| Aerosols | 2 | 2020 | 65 | 0.090 |
Why?
|
| Asthma | 1 | 2018 | 746 | 0.090 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2018 | 653 | 0.080 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2018 | 786 | 0.080 |
Why?
|
| Depression | 1 | 2018 | 1220 | 0.080 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2020 | 143 | 0.080 |
Why?
|
| Parents | 1 | 2016 | 1017 | 0.080 |
Why?
|
| Healthy Volunteers | 2 | 2020 | 131 | 0.080 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 865 | 0.080 |
Why?
|
| Mutation | 1 | 2021 | 5771 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2040 | 0.070 |
Why?
|
| Obesity | 1 | 2018 | 2091 | 0.070 |
Why?
|
| Neoplasms | 1 | 2021 | 2746 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2023 | 1240 | 0.070 |
Why?
|
| Platelet Function Tests | 1 | 2025 | 38 | 0.060 |
Why?
|
| Coronary Artery Bypass | 2 | 2019 | 485 | 0.060 |
Why?
|
| Network Meta-Analysis | 1 | 2024 | 37 | 0.060 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2024 | 36 | 0.060 |
Why?
|
| Awareness | 1 | 2024 | 81 | 0.060 |
Why?
|
| Homosexuality, Male | 1 | 2024 | 60 | 0.060 |
Why?
|
| Lymphocyte Count | 1 | 2023 | 114 | 0.060 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 67 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2024 | 267 | 0.050 |
Why?
|
| Bandages | 1 | 2023 | 56 | 0.050 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2023 | 97 | 0.050 |
Why?
|
| Tongue | 1 | 2023 | 30 | 0.050 |
Why?
|
| Cyanosis | 1 | 2023 | 41 | 0.050 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 1 | 2024 | 115 | 0.050 |
Why?
|
| Respiration | 1 | 2023 | 123 | 0.050 |
Why?
|
| Universities | 1 | 2023 | 126 | 0.050 |
Why?
|
| Angioplasty | 1 | 2022 | 85 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 2024 | 234 | 0.050 |
Why?
|
| Aftercare | 1 | 2023 | 145 | 0.050 |
Why?
|
| Potassium | 1 | 2022 | 278 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 232 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 319 | 0.050 |
Why?
|
| alpha-Amylases | 1 | 2021 | 9 | 0.050 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2021 | 20 | 0.050 |
Why?
|
| Drug Recalls | 1 | 2020 | 4 | 0.050 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 35 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 1683 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2022 | 151 | 0.050 |
Why?
|
| Emotions | 1 | 2023 | 364 | 0.040 |
Why?
|
| Coronavirus, Canine | 1 | 2020 | 1 | 0.040 |
Why?
|
| Head Protective Devices | 1 | 2020 | 24 | 0.040 |
Why?
|
| Airway Extubation | 1 | 2021 | 67 | 0.040 |
Why?
|
| Saliva | 1 | 2021 | 113 | 0.040 |
Why?
|
| Reference Values | 1 | 2022 | 694 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2021 | 214 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2020 | 35 | 0.040 |
Why?
|
| Particle Size | 1 | 2020 | 116 | 0.040 |
Why?
|
| Zoonoses | 1 | 2020 | 43 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2025 | 442 | 0.040 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 80 | 0.040 |
Why?
|
| Patient Simulation | 1 | 2020 | 39 | 0.040 |
Why?
|
| Acute Disease | 1 | 2023 | 1089 | 0.040 |
Why?
|
| Dog Diseases | 1 | 2020 | 49 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2022 | 670 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2020 | 192 | 0.040 |
Why?
|
| Radial Artery | 1 | 2019 | 26 | 0.040 |
Why?
|
| Students, Nursing | 1 | 2019 | 19 | 0.040 |
Why?
|
| Diffusion of Innovation | 1 | 2020 | 97 | 0.040 |
Why?
|
| Species Specificity | 1 | 2020 | 547 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 468 | 0.040 |
Why?
|
| Dogs | 1 | 2020 | 762 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 554 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 540 | 0.040 |
Why?
|
| Spain | 1 | 2018 | 53 | 0.040 |
Why?
|
| Tomography | 1 | 2018 | 41 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2018 | 115 | 0.040 |
Why?
|
| Task Performance and Analysis | 1 | 2018 | 95 | 0.040 |
Why?
|
| Hypothermia | 1 | 2018 | 54 | 0.040 |
Why?
|
| Length of Stay | 1 | 2023 | 1281 | 0.040 |
Why?
|
| Range of Motion, Articular | 1 | 2018 | 71 | 0.040 |
Why?
|
| Transportation of Patients | 1 | 2018 | 55 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2022 | 1102 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2018 | 156 | 0.040 |
Why?
|
| Program Development | 1 | 2018 | 189 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2018 | 102 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 1418 | 0.030 |
Why?
|
| Fingers | 1 | 2016 | 65 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2018 | 347 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 195 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1240 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2018 | 237 | 0.030 |
Why?
|
| Patient Safety | 1 | 2020 | 390 | 0.030 |
Why?
|
| Testosterone | 1 | 2021 | 462 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 2018 | 234 | 0.030 |
Why?
|
| Unconsciousness | 1 | 2015 | 17 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 1992 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2018 | 1003 | 0.030 |
Why?
|
| Echocardiography | 1 | 2021 | 1069 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 359 | 0.030 |
Why?
|
| Medical Records | 1 | 2015 | 189 | 0.030 |
Why?
|
| Software | 1 | 2019 | 673 | 0.030 |
Why?
|
| Schools | 1 | 2016 | 210 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 586 | 0.030 |
Why?
|
| Accidental Falls | 1 | 2015 | 106 | 0.030 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2018 | 425 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 1583 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1787 | 0.020 |
Why?
|
| Animals | 1 | 2020 | 33618 | 0.010 |
Why?
|